Entero Healthcare Solutions Ltd

Entero Healthcar Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Entero Healthcare Solutions Ltd

₹ 1,147 1.40%
30 Jun - close price
enterohealthcare.com BSE: 544122 NSE: ENTERO
About

Incorporated in 2018, Entero Healthcare
Solutions Ltd is in the business of distribution
and marketing of pharmaceutical and surgical products and allied services[1]

Key Points

Business Overview:[1]
EHSL, a leading Healthcare Supply Chain Solutions Specialist, ranks among India’s top three healthcare product distributors by revenue, offering demand fulfillment and generation solutions to manufacturers.

Website BSE NSE
  • Market Cap ₹ 4,991 Cr.
  • Current Price ₹ 1,147
  • High / Low ₹ 1,584 / 1,042
  • Stock P/E 52.6
  • Book Value ₹ 396
  • Dividend Yield 0.00 %
  • ROCE 8.72 %
  • ROE 5.64 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter
  • Company has delivered good profit growth of 152% CAGR over last 5 years

Cons

  • Stock is trading at 2.89 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Consumer Services Retailing Pharmacy Retail

Part of BSE SmallCap BSE IPO BSE Allcap BSE Consumer Discretionary Nifty Microcap 250

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
829 887 899 996 993 1,034 1,097 1,301 1,359 1,339
810 867 873 968 964 1,005 1,067 1,258 1,309 1,290
Operating Profit 19 20 26 29 29 29 30 42 50 49
OPM % 2% 2% 3% 3% 3% 3% 3% 3% 4% 4%
2 1 1 2 2 9 13 11 8 7
Interest 13 13 14 18 16 17 10 11 10 10
Depreciation 5 7 6 6 6 7 7 7 8 8
Profit before tax 2 1 7 7 8 14 27 35 39 37
Tax % -44% 490% 6% 23% 16% -56% 25% 25% 25% 16%
4 -4 6 5 7 21 21 26 29 31
EPS in Rs 8.05 -9.05 15.18 3.19 4.22 4.82 4.62 5.43 5.85 5.91
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1,350 1,773 2,522 3,300 3,922 5,096
1,326 1,758 2,498 3,236 3,810 4,924
Operating Profit 23 15 24 64 112 172
OPM % 2% 1% 1% 2% 3% 3%
5 11 4 6 14 40
Interest 13 20 29 49 66 42
Depreciation 12 16 20 24 25 31
Profit before tax 4 -11 -20 -4 36 139
Tax % 67% 42% 49% 201% -12% 23%
1 -15 -29 -11 40 107
EPS in Rs 93.81 -1,550.90 -77.71 -28.12 8.99 21.80
Dividend Payout % 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 30%
3 Years: 26%
TTM: 30%
Compounded Profit Growth
10 Years: %
5 Years: 152%
3 Years: 73%
TTM: 143%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 8%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.10 0.10 4 4 43 44
Reserves -16 -32 -62 -73 1,595 1,681
603 720 974 1,101 338 385
162 147 210 275 369 593
Total Liabilities 749 836 1,125 1,308 2,345 2,703
186 189 262 268 289 560
CWIP 2 2 1 0 0 0
Investments 0 0 0 0 0 58
560 645 863 1,040 2,056 2,085
Total Assets 749 836 1,125 1,308 2,345 2,703

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-37 -69 -35 -45 -37 -77
-203 -31 -162 -49 -704 220
217 89 211 73 863 -74
Net Cash Flow -23 -11 14 -21 122 69

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 63 50 54 57 57 59
Inventory Days 57 54 49 41 43 52
Days Payable 32 22 22 25 24 31
Cash Conversion Cycle 88 82 81 73 77 80
Working Capital Days 88 85 79 72 71 92
ROCE % 1% 1% 5% 7% 9%

Shareholding Pattern

Numbers in percentages

Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
52.44% 52.44% 52.44% 52.44% 52.42%
23.30% 23.32% 23.82% 22.20% 19.92%
2.28% 2.06% 7.73% 8.78% 9.63%
21.99% 22.18% 16.02% 16.59% 18.03%
No. of Shareholders 80,86466,40036,76733,17233,159

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls